Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse.
Authors: Barrachina L, Romero A, Zaragoza P, Rodellar C, Vázquez F J
Journal: Veterinary journal (London, England : 1997)
Summary
# Editorial Summary: Mesenchymal Stem Cells in Equine Practice As MSC-based therapies become increasingly common in equine musculoskeletal medicine, practitioners need practical guidance on handling these cells from harvest through clinical application—yet significant gaps remain between laboratory production and consistent clinical outcomes. Barrachina and colleagues conducted a comprehensive review of factors affecting MSC viability and efficacy throughout the treatment pathway, examining laboratory procedures, shipping protocols, administration routes, injection techniques, and the compatibility of commonly used adjunctive products with living cells. The authors identified critical variables that either preserve or compromise cell function: shipping conditions significantly impact cell viability before delivery, administration route and injection methodology influence engraftment success, and certain commonly combined therapeutics (such as some corticosteroids and local anaesthetics) actively damage MSCs in vitro whilst others appear neutral or beneficial. For practitioners utilising MSC therapies, this means attention to detail across the entire treatment chain—from transportation temperature to which products are co-injected—directly affects whether cells remain viable enough to exert therapeutic effects at the injury site. Whilst the review highlights substantial knowledge gaps in equine MSC biology, the authors emphasise that optimising currently understood variables is essential to improve treatment consistency and build a stronger evidence base for these increasingly popular but still incompletely understood cellular therapies.
Read the full abstract on PubMed
Practical Takeaways
- •Control shipping conditions and handling protocols from cell isolation to delivery, as these directly impact cell viability and treatment success rates
- •Be selective when combining MSC treatments with other products; some medications or additives can damage cells, so verify compatibility before use
- •Follow evidence-based injection techniques and administration routes specific to the injury location, as these choices affect therapeutic outcomes
Key Findings
- •Multiple factors from tissue harvesting through cell delivery significantly affect MSC viability and efficacy in equine patients
- •Shipping conditions, routes of administration, and injection methods are critical variables that practitioners must manage to optimize MSC-based therapy outcomes
- •Certain commonly used products have deleterious effects on MSCs and should be avoided during MSC therapy, while others may be safely combined
- •Significant knowledge gaps remain regarding MSC-based therapies in horses, requiring careful management of known affecting factors to strengthen evidence basis